New Frontiers in Biosimilar Pathways

April 16, 2013

US manufacturers prepare for expanding biosimilar market opportunities as this exciting landscape takes shape. The production of biosimilars poses challenges as pharma looks to curb health care spending.
US manufacturers prepare for expanding biosimilar market opportunities as this exciting landscape takes shape. The production of biosimilars poses challenges as pharma looks to curb health care spending. Molly Burich, Assistant Director of Distribution/Specialty Pharmacy Strategy, Oncology Policy & Reimbursement for Xcenda bylines the article.